Free Trial
NASDAQ:TLRY

Tilray Brands Q1 2026 Earnings Report

Tilray Brands logo
$1.62 +0.01 (+0.62%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$1.64 +0.02 (+1.54%)
As of 10/3/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tilray Brands EPS Results

Actual EPS
N/A
Consensus EPS
-$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Tilray Brands Revenue Results

Actual Revenue
N/A
Expected Revenue
$205.75 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tilray Brands Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
Thursday, October 9, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Tilray Brands Earnings Headlines

Should You Buy Tilray Brands Stock Before Oct. 9?
URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
See More Tilray Brands Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tilray Brands? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tilray Brands and other key companies, straight to your email.

About Tilray Brands

Tilray Brands (NASDAQ:TLRY) is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products. The company has expanded into adjacent consumer categories via strategic acquisitions, integrating brands in hemp foods, craft beverages and pet wellness. This diversified approach supports Tilray Brands’ goal of serving both medical and adult-use markets while extending its reach into broader lifestyle and health-and-wellness segments.

Founded in 2013, Tilray became the first global cannabis company to list on a major U.S. exchange in 2018. In 2021, it completed a transformative merger with Aphria, creating one of the world’s largest cannabis companies by production capacity. Headquartered in New York with integrated operations in Canada, the United States, Europe, Australia, Latin America and the Caribbean, Tilray Brands leverages international scale to access regulated markets and support global research collaborations.

Tilray Brands is led by a management team with deep experience in consumer packaged goods, pharmaceuticals and regulated industries. The company’s executive leadership emphasizes product innovation, regulatory compliance and operational excellence, positioning Tilray Brands to pursue growth opportunities across its core cannabis business and complementary consumer lifestyle categories.

View Tilray Brands Profile

More Earnings Resources from MarketBeat